Mavrou, A., & Oltean, S. (2016). SRPK1 inhibition in prostate cancer: A novel anti-angiogenic treatment through modulation of VEGF alternative splicing. Pharmacol Res.
Παραπομπή Chicago StyleMavrou, Athina, και Sebastian Oltean. "SRPK1 Inhibition in Prostate Cancer: A Novel Anti-angiogenic Treatment Through Modulation of VEGF Alternative Splicing." Pharmacol Res 2016.
Παραπομπή MLAMavrou, Athina, και Sebastian Oltean. "SRPK1 Inhibition in Prostate Cancer: A Novel Anti-angiogenic Treatment Through Modulation of VEGF Alternative Splicing." Pharmacol Res 2016.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.